$SPTY
SPECIFICITY, INC.

2023 Q3 Form 10-Q Financial Statement

#000152013823000504 Filed on November 20, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2022 Q3
Revenue $320.3K $663.0K
YoY Change -51.69% 209.65%
Cost Of Revenue $26.63K $338.9K
YoY Change -92.14% 286.78%
Gross Profit $293.6K $324.1K
YoY Change -9.4% 156.22%
Gross Profit Margin 91.69% 48.89%
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $223.7K $1.249M
YoY Change -82.09% 339.33%
Operating Profit $69.97K -$924.6K
YoY Change -107.57% 486.16%
Interest Expense $17.50K $24.93K
YoY Change -29.81% -29.6%
% of Operating Profit 25.01%
Other Income/Expense, Net -$17.50K -$24.93K
YoY Change -29.81% -29.6%
Pretax Income
YoY Change
Income Tax
% Of Pretax Income
Net Earnings $52.47K -$949.5K
YoY Change -105.53% 391.59%
Net Earnings / Revenue 16.38% -143.22%
Basic Earnings Per Share $0.00 -$0.04
Diluted Earnings Per Share $0.00 -$0.04
COMMON SHARES
Basic Shares Outstanding 10.78M shares 9.369M shares
Diluted Shares Outstanding 10.78M shares 9.369M shares

Balance Sheet

Concept 2023 Q3 2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $5.317K $172.6K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables $75.63K
Other Receivables
Total Short-Term Assets $90.24K $213.2K
YoY Change -57.68%
LONG-TERM ASSETS
Property, Plant & Equipment $62.89K $73.36K
YoY Change -14.28%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $95.89K $148.3K
YoY Change -35.33%
TOTAL ASSETS
Total Short-Term Assets $90.24K $213.2K
Total Long-Term Assets $95.89K $148.3K
Total Assets $186.1K $361.5K
YoY Change -48.51%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $103.6K $68.35K
YoY Change 51.63%
Accrued Expenses $43.11K $23.68K
YoY Change 82.05%
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $874.3K $168.3K
YoY Change 419.53%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $874.3K $168.3K
Total Long-Term Liabilities
Total Liabilities $1.874M $1.190M
YoY Change 57.51%
SHAREHOLDERS EQUITY
Retained Earnings -$7.676M -$4.741M
YoY Change 61.93%
Common Stock $10.81K $9.867K
YoY Change 9.58%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$1.688M -$828.4K
YoY Change
Total Liabilities & Shareholders Equity $186.1K $361.5K
YoY Change -48.51%

Cashflow Statement

Concept 2023 Q3 2022 Q3
OPERATING ACTIVITIES
Net Income $52.47K -$949.5K
YoY Change -105.53% 391.59%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Central Index Key
EntityCentralIndexKey
0001840102
CY2022Q4 spty Accrued Interest Related Party
AccruedInterestRelatedParty
usd
CY2022Q4 us-gaap Notes Payable Current
NotesPayableCurrent
usd
CY2022Q4 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
usd
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
usd
spty Payment Of Deferred Offering Costs
PaymentOfDeferredOfferingCosts
usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
spty Right Of Use Asset And Liability
RightOfUseAssetAndLiability
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
333-257323
dei Entity Registrant Name
EntityRegistrantName
SPECIFICITY, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
85-4017786
dei Entity Address Address Line1
EntityAddressAddressLine1
410 S. Ware Blvd.
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 508
dei Entity Address City Or Town
EntityAddressCityOrTown
Tampa
dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
33619
dei City Area Code
CityAreaCode
(813)
dei Local Phone Number
LocalPhoneNumber
364-4744
dei Security12b Title
Security12bTitle
Common Stock
dei Trading Symbol
TradingSymbol
SPTY
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
10694243 shares
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5317 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
22818 usd
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
75633 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
8182 usd
CY2023Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
9292 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
235375 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
90242 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
266375 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
62888 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
70722 usd
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
33004 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
64632 usd
CY2023Q3 us-gaap Assets
Assets
186134 usd
CY2022Q4 us-gaap Assets
Assets
401729 usd
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
103642 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
93867 usd
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
43111 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
37828 usd
CY2023Q3 spty Accrued Interest Related Party
AccruedInterestRelatedParty
37500 usd
CY2023Q3 us-gaap Notes Payable Current
NotesPayableCurrent
116959 usd
CY2023Q3 spty Related Party Advances
RelatedPartyAdvances
367000 usd
CY2022Q4 spty Related Party Advances
RelatedPartyAdvances
193739 usd
CY2023Q3 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
10000 usd
CY2023Q3 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
173110 usd
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
33004 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
43909 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
874326 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
369343 usd
CY2023Q3 spty Related Party Notes Payable
RelatedPartyNotesPayable
1000000 usd
CY2022Q4 spty Related Party Notes Payable
RelatedPartyNotesPayable
1000000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
20723 usd
CY2023Q3 us-gaap Liabilities
Liabilities
1874326 usd
CY2022Q4 us-gaap Liabilities
Liabilities
1390066 usd
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
10782584 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
10782584 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
10652584 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
10652584 shares
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
10812 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
10652 usd
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
4576253 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
4401413 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-7676257 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-6801402 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-1688192 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-988337 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
186134 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
401729 usd
CY2023Q3 us-gaap Revenues
Revenues
320271 usd
CY2022Q3 us-gaap Revenues
Revenues
378660 usd
us-gaap Revenues
Revenues
805317 usd
us-gaap Revenues
Revenues
649510 usd
CY2023Q3 us-gaap Cost Of Revenue
CostOfRevenue
26625 usd
CY2022Q3 us-gaap Cost Of Revenue
CostOfRevenue
110360 usd
us-gaap Cost Of Revenue
CostOfRevenue
263825 usd
us-gaap Cost Of Revenue
CostOfRevenue
261250 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
293646 usd
CY2022Q3 us-gaap Gross Profit
GrossProfit
268300 usd
us-gaap Gross Profit
GrossProfit
541492 usd
us-gaap Gross Profit
GrossProfit
388260 usd
CY2023Q3 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
17081 usd
CY2022Q3 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
19837 usd
us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
73091 usd
us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
32717 usd
CY2023Q3 us-gaap Share Based Compensation
ShareBasedCompensation
0 usd
CY2022Q3 us-gaap Share Based Compensation
ShareBasedCompensation
0 usd
us-gaap Share Based Compensation
ShareBasedCompensation
233505 usd
us-gaap Share Based Compensation
ShareBasedCompensation
600000 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
191199 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
587611 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1160333 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1922740 usd
CY2023Q3 us-gaap Officers Compensation
OfficersCompensation
15400 usd
CY2022Q3 us-gaap Officers Compensation
OfficersCompensation
20988 usd
us-gaap Officers Compensation
OfficersCompensation
76673 usd
us-gaap Officers Compensation
OfficersCompensation
116518 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
223680 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
628436 usd
us-gaap Operating Expenses
OperatingExpenses
1310097 usd
us-gaap Operating Expenses
OperatingExpenses
2071975 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
69966 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-360136 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-768605 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-1683715 usd
CY2023Q3 us-gaap Interest Expense
InterestExpense
17500 usd
CY2022Q3 us-gaap Interest Expense
InterestExpense
12466 usd
us-gaap Interest Expense
InterestExpense
106250 usd
us-gaap Interest Expense
InterestExpense
23014 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-17500 usd
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-12466 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-106250 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-23014 usd
CY2023Q3 us-gaap Profit Loss
ProfitLoss
52466 usd
CY2022Q3 us-gaap Profit Loss
ProfitLoss
-372602 usd
us-gaap Profit Loss
ProfitLoss
-874855 usd
us-gaap Profit Loss
ProfitLoss
-1706729 usd
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.08
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.08
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.19
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.19
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10782584 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10782584 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9369345 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9369345 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10669435 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10669435 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9123984 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9123984 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-988337 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
175000 usd
us-gaap Net Income Loss
NetIncomeLoss
-874855 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-1688192 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-1840658 usd
CY2023Q3 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
100000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
52466 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-1688192 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-379819 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1263713 usd
us-gaap Noninterest Expense Offering Cost
NoninterestExpenseOfferingCost
28685 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
600000 usd
us-gaap Net Income Loss
NetIncomeLoss
-2283652 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-828443 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-1037412 usd
CY2022Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
791746 usd
CY2022Q3 us-gaap Noninterest Expense Offering Cost
NoninterestExpenseOfferingCost
5854 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-576923 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-828443 usd
us-gaap Profit Loss
ProfitLoss
-874855 usd
us-gaap Profit Loss
ProfitLoss
-1706729 usd
us-gaap Share Based Compensation
ShareBasedCompensation
233505 usd
us-gaap Share Based Compensation
ShareBasedCompensation
600000 usd
us-gaap Depreciation
Depreciation
7834 usd
us-gaap Depreciation
Depreciation
4769 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
10000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
67451 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
7422 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3557 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
9775 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-21246 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
5283 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-10333 usd
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-37500 usd
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-12466 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-645831 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1124630 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
9207 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-9207 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
120000 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
3041 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
173261 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
73000 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
200000 usd
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
36890 usd
spty Payment Of Deferred Offering Costs
PaymentOfDeferredOfferingCosts
-22831 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
175000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
471967 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
628330 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
522136 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-17501 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-611701 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
22818 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
637841 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5317 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
26140 usd
us-gaap Interest Paid Net
InterestPaidNet
58750 usd
us-gaap Interest Paid Net
InterestPaidNet
10548 usd
spty Right Of Use Asset And Liability
RightOfUseAssetAndLiability
104665 usd
us-gaap Nature Of Operations
NatureOfOperations
<p id="xdx_808_eus-gaap--NatureOfOperations_zJWLuOIPgObg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>NOTE 1 - <span id="xdx_82B_zMQieYb8dhl4">ORGANIZATION AND DESCRIPTION OF BUSINESS</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Specificity, Inc. (the “Company”) is a Nevada Corporation incorporated on November 25, 2020 (“Inception”).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company is a full-service digital marketing firm that delivers cutting-edge marketing solutions to business-to-business clients as well as business to consumer clients. The Company has developed tools that allow us to identify and market to people who are actively in the buying cycle. We take advantage of the real-time messaging opportunities digital marketing offers to give small and medium-sized businesses a fair chance at online traffic.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_841_eus-gaap--UseOfEstimates_znduWkFF5wA" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span style="text-decoration: underline"><span id="xdx_867_zeuoVhzBqoj6">Use of Estimates</span></span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of the financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_845_eus-gaap--ConcentrationRiskCreditRisk_z0Z5HsSByakb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span style="text-decoration: underline"><span id="xdx_865_z57SXE2SsTzb">Concentration of Credit Risk</span></span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Cash and cash equivalents are maintained at financial institutions and, at times, balances may exceed federally insured limits of $<span id="xdx_904_eus-gaap--CashFDICInsuredAmount_c20230930_pp0p0" title="FDIC limit">250,000</span> per institution that pays Federal Deposit Insurance Corporation (“FDIC”) insurance premiums. The Company has never experienced any losses related to these balances.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2023Q3 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 usd
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
us-gaap Profit Loss
ProfitLoss
-874855 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-645831 usd
CY2020Q4 us-gaap Payments To Acquire Software
PaymentsToAcquireSoftware
50000 usd
CY2023Q3 spty Related Party Advances
RelatedPartyAdvances
367000 usd
spty Rent Expense
RentExpense
66571 usd
spty Rent Expense
RentExpense
95536 usd
CY2022Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
104665 usd
CY2022Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
104665 usd
CY2023Q3 us-gaap Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
0.03 pure
CY2023Q3 spty Amounts Due To Related Party
AmountsDueToRelatedParty
40000 usd
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001

Files In Submission

Name View Source Status
0001520138-23-000504-index-headers.html Edgar Link pending
0001520138-23-000504-index.html Edgar Link pending
0001520138-23-000504.txt Edgar Link pending
0001520138-23-000504-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
spec-20230930_10q.htm Edgar Link pending
spec-20230930_10qex31z1.htm Edgar Link pending
spec-20230930_10qex32z1.htm Edgar Link pending
spty-20230930.xsd Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
spec-20230930_10q_htm.xml Edgar Link completed
spty-20230930_def.xml Edgar Link unprocessable
spty-20230930_cal.xml Edgar Link unprocessable
spty-20230930_lab.xml Edgar Link unprocessable
spty-20230930_pre.xml Edgar Link unprocessable